LU70941A1 - - Google Patents

Info

Publication number
LU70941A1
LU70941A1 LU70941A LU70941A LU70941A1 LU 70941 A1 LU70941 A1 LU 70941A1 LU 70941 A LU70941 A LU 70941A LU 70941 A LU70941 A LU 70941A LU 70941 A1 LU70941 A1 LU 70941A1
Authority
LU
Luxembourg
Application number
LU70941A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU70941A1 publication Critical patent/LU70941A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24Y being a hetero atom
    • C07C279/26X and Y being nitrogen atoms, i.e. biguanides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU70941A 1973-09-19 1974-09-17 LU70941A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7333647A FR2243684B1 (cg-RX-API-DMAC7.html) 1973-09-19 1973-09-19

Publications (1)

Publication Number Publication Date
LU70941A1 true LU70941A1 (cg-RX-API-DMAC7.html) 1975-03-06

Family

ID=9125267

Family Applications (1)

Application Number Title Priority Date Filing Date
LU70941A LU70941A1 (cg-RX-API-DMAC7.html) 1973-09-19 1974-09-17

Country Status (9)

Country Link
US (1) US3957853A (cg-RX-API-DMAC7.html)
JP (1) JPS5053520A (cg-RX-API-DMAC7.html)
BE (1) BE820072A (cg-RX-API-DMAC7.html)
DE (1) DE2444532A1 (cg-RX-API-DMAC7.html)
ES (1) ES430174A1 (cg-RX-API-DMAC7.html)
FR (1) FR2243684B1 (cg-RX-API-DMAC7.html)
GB (1) GB1432325A (cg-RX-API-DMAC7.html)
LU (1) LU70941A1 (cg-RX-API-DMAC7.html)
NL (1) NL7412427A (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2611501B1 (fr) * 1987-03-04 1991-12-06 Corbiere Jerome Nouvelles compositions pharmaceutiques pour la voie buccale a base d'acetylsalielylate de lysine et leur procede d'obtention
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
FR2796551B1 (fr) * 1999-07-23 2003-07-25 Lipha Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant
FR2796940B1 (fr) * 1999-07-26 2005-04-08 Lipha Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant
US6866866B1 (en) * 2000-11-03 2005-03-15 Andrx Labs, Llc Controlled release metformin compositions
US6790459B1 (en) 2000-11-03 2004-09-14 Andrx Labs, Llc Methods for treating diabetes via administration of controlled release metformin
CA2427195C (en) 2000-11-03 2009-10-06 Andrx Corporation Controlled release metformin compositions
US20060034922A1 (en) * 2000-11-03 2006-02-16 Andrx Labs, Llc Controlled release metformin compositions
US20040052848A1 (en) * 2002-05-23 2004-03-18 Xiu-Xiu Cheng Biguanide formulations
US20050048119A1 (en) * 2002-09-20 2005-03-03 Avinash Nangia Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
US20050051922A1 (en) * 2002-09-20 2005-03-10 Avinash Nangia Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
EP2604266A1 (en) 2002-09-20 2013-06-19 Andrx Labs Llc Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
JP2007509973A (ja) * 2003-10-31 2007-04-19 アルザ・コーポレーシヨン 増強された吸収のための組成物および投与形態物
US8058312B2 (en) * 2007-01-29 2011-11-15 Hanall Biopharma Co., Ltd. N, N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same
JP5292404B2 (ja) * 2007-09-21 2013-09-18 ハンオル バイオファーマ カンパニー,リミテッド N,n−ジメチルイミドジカルボンイミド酸ジアミドのジカルボン酸塩、その製造方法、及びその薬剤学的組成物
MX2011000135A (es) 2008-06-26 2011-02-25 Silanes Sa De Cv Lab Una nueva sal de glicinato de metformina para el control de la glucosa en sangre.
WO2010146604A2 (en) 2009-06-18 2010-12-23 Exemed Pharmaceuticals Processes for preparing metformin hydrochloride
WO2011049400A2 (ko) * 2009-10-23 2011-04-28 한올바이오파마주식회사 N,n-디메틸 이미도디카르본이미딕 디아미드의 산 부가염을 포함하는 항암용 약제학적 조성물
CN101691344B (zh) * 2009-10-26 2012-10-17 漆又毛 一种二甲双胍酸式复盐化合物及制备方法
KR101878252B1 (ko) 2010-05-26 2018-07-13 브이티브이 테라퓨틱스 엘엘씨 글루코키나아제 활성화제와 병용되는 메트포르민의 용도, 및 메트포르민과 글루코키나아제 활성화제를 포함하는 조성물
US8440723B2 (en) * 2011-05-11 2013-05-14 Banavara L. Mylari Metformin salts of salicylic acid and its congeners
HK1202458A1 (en) 2012-05-17 2015-10-02 Vtv治疗有限责任公司 Glucokinase activator compositions for the treatment of diabetes
WO2018060959A1 (en) 2016-09-30 2018-04-05 Laboratorios Silanes S.A. De C.V. Metformin glycinate, pharmaceutical compositions comprising the same, and methods of using the same
WO2018060962A2 (en) 2016-09-30 2018-04-05 Laboratorios Silanes S.A. De C.V. Metformin amino acid compounds and methods of using the same
CN107118130A (zh) * 2017-05-11 2017-09-01 杜剑平 一类治疗肿瘤的药物化合物及其应用
MX2020008905A (es) 2018-06-12 2020-12-03 Vtv Therapeutics Llc Usos terapeuticos de activadores de glucoquinasa en combinacion con insulina o analogos de insulinas.
US12391658B2 (en) 2020-02-18 2025-08-19 Vtv Therapeutics Llc Sulfoxide and sulfone glucokinase activators and methods of use thereof
CN115073331A (zh) * 2021-03-15 2022-09-20 中国医学科学院药物研究所 二甲双胍肉桂酸盐一水合物及制备方法和其组合物与用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE568513A (cg-RX-API-DMAC7.html) *
FR1295304A (fr) * 1956-05-07 1962-06-08 Equilibre Biolog L Nouveau sel de l'acide acétyl-salicylique et son procédé de préparation
US2983750A (en) * 1959-07-03 1961-05-09 Bristol Myers Co Tris methylammonium salicylate salts
GB883331A (en) * 1959-08-28 1961-11-29 Mead Johnson & Co Stable water-soluble acetylsalicylic acid derivative

Also Published As

Publication number Publication date
FR2243684B1 (cg-RX-API-DMAC7.html) 1977-01-28
FR2243684A1 (cg-RX-API-DMAC7.html) 1975-04-11
BE820072A (fr) 1975-01-16
NL7412427A (nl) 1975-03-21
ES430174A1 (es) 1976-10-16
JPS5053520A (cg-RX-API-DMAC7.html) 1975-05-12
GB1432325A (en) 1976-04-14
DE2444532A1 (de) 1975-03-27
US3957853A (en) 1976-05-18

Similar Documents

Publication Publication Date Title
AU476761B2 (cg-RX-API-DMAC7.html)
AU474593B2 (cg-RX-API-DMAC7.html)
FR2243684B1 (cg-RX-API-DMAC7.html)
AU474838B2 (cg-RX-API-DMAC7.html)
AU476714B2 (cg-RX-API-DMAC7.html)
AU476696B2 (cg-RX-API-DMAC7.html)
FR2220256B1 (cg-RX-API-DMAC7.html)
AU477823B2 (cg-RX-API-DMAC7.html)
AU471461B2 (cg-RX-API-DMAC7.html)
AU476873B1 (cg-RX-API-DMAC7.html)
AR195948A1 (cg-RX-API-DMAC7.html)
AR196382A1 (cg-RX-API-DMAC7.html)
AR196123Q (cg-RX-API-DMAC7.html)
AR196212Q (cg-RX-API-DMAC7.html)
BG19655A1 (cg-RX-API-DMAC7.html)
AU479504A (cg-RX-API-DMAC7.html)
CH563016A5 (cg-RX-API-DMAC7.html)
CH561321A5 (cg-RX-API-DMAC7.html)
CH559090A5 (cg-RX-API-DMAC7.html)
CH217674A4 (cg-RX-API-DMAC7.html)
BG20243A1 (cg-RX-API-DMAC7.html)
BG20214A1 (cg-RX-API-DMAC7.html)
CH563596A5 (cg-RX-API-DMAC7.html)
BG19027A1 (cg-RX-API-DMAC7.html)
BG18730A1 (cg-RX-API-DMAC7.html)